STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
STSA SATSUMA PHARMACEUTICALS INCORPORATED StockScouter® Report
2
StockScouter® Score
SATSUMA PHARMACEUTICALS INCORPORATED, a micro cap company in the healthcare sector, is expected to underperform the market over the next six months with higher than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- Short-term relative price momentum exhibits meaningful strength. Postive
Concerns
- Earnings growth in the past year has decelerated rapidly compared to earnings growth in the past three years. Negative
- Moving average analysis for STSA suggests weak price movement over the medium term. Negative
- The most recent quarterly earnings report was slightly lower than analysts’ consensus forecast. Neutral/Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be neutral, stocks will be , and healthcare stocks will be neutral.
Expected Risk/Return
Core Model Grades
F
C
N/A
F